In the cases of SSA/Ps with carcinoma, MUC5AC immuno-expression was observed in 100% of SSA/Ps, in 62.5% of carcinoma, and irregularly in invasive carcinomas [107]. The gene discussed is MUC5AC; the disease is carcinoma.